Competitive Problems in the Drug Industry, 24. sējums

accordance active ingredient ADDITIONAL REQUIREMENTS agencies Amendment-1 Ampicillin batch bioavailability Capsules Chairman CHLORPHENIRAMINE MALEATE Classification of Defects Closure Color Limits Company compliance comply content uniformity contract contractor date of manufacture DEFENSE MEDICAL PURCHASE Delete delivery Department of Defense Depot determined Dextroamphetamine digoxin DPSC Drug Administration drug products Eli Lilly Explanatory Notes Exterior container FDA's Federal Food Federal Stock FELDMANN fiberboard fiberboard box firms Food and Drug Formulary Gaylord Nelson GMPs Government Gram Guaiacolate Hydrochloride Hydrochloride Tablets Immediate containers Injection Intermediate package Item Identification label Laboratories Labs Lederle manufacturing practices material MEDICAL PURCHASE DESCRIPTION Meprobamate monograph Office Patent percent Pfizer Pharmaceutical pharmacist Phenylephrine problem procurement quality assurance quantity request response samples Senator NELSON Simethicone sodium diphenylhydantoin solution standards statement sterile Sulfate supplier Supply syrup Theophylline tion unit of issue Unit package